A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Cantabell Tab
Candemore Plus Tab
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- over 19 years old
- Agreement with written informed consent
- Hypertensive Patients
Exclusion Criteria:
- Patients with secondary hypertension
- Participated in other trial within 30 days
- In investigator's judgement
Sites / Locations
- Ajou University Hospital
- Hallym Univ. Medical Center
- Daegu Catholic Univ. Medical Center
- MYONGJI Hospital
- Inje University Ilsan Paik Hospital
- Gachon University Gil Medical Center
- Jeju National University Hospital
- Gangnam Severance Hospital
- Hallym University Kangnam Sacred Heart Hospital
- Hanyang University Medical Center
- Kangbuk Samsung Hospital
- SNU Boramae Medical Center
- Ulsan University Hospital
- Wonju Severance Christian Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
A
B
Arm Description
Outcomes
Primary Outcome Measures
cSBP(central Systolic Blood Pressure)
Average cSBP change after 8 weeks compared to baseline
Secondary Outcome Measures
cDBP(central Diastolic Blood Pressure)
Average cDBP change after 8 weeks compared to baseline
sitSBP(sitting Systolic Blood Pressure)
Average sitSBP change after 8 weeks compared to baseline
sitDBP(sitting Diastolic Blood Pressure)
Average sitDBP change after 8 weeks compared to baseline
Full Information
NCT ID
NCT04521023
First Posted
August 18, 2020
Last Updated
August 18, 2020
Sponsor
Chong Kun Dang Pharmaceutical
1. Study Identification
Unique Protocol Identification Number
NCT04521023
Brief Title
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Official Title
A Randomized, Double-blind, Non-inferiority, Multi-center, Phase 4 Trial to Evaluate the Blood Pressure Lowering Effect of a Candesartan/Hydrochlorothiazide(Candemore Plus® Tab) Versus Candesartan/Amlodipine(Cantabell® Tab) in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
September 20, 2017 (Actual)
Primary Completion Date
January 28, 2020 (Actual)
Study Completion Date
June 3, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chong Kun Dang Pharmaceutical
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Phase 4 clinical trial to Evaluate the blood pressure lowering effect of a Candesartan/Hydrochlorothiazide(Candemore Plus Tab) versus Candesartan/Amlodipine(Cantabell Tab) in Hypertensive Patients
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
132 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Title
B
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Cantabell Tab
Intervention Description
Patients assigned to experimental group are treated with Cantabell Tab
Intervention Type
Drug
Intervention Name(s)
Candemore Plus Tab
Intervention Description
Patients assigned to experimental group are treated with Candemore Plus Tab
Primary Outcome Measure Information:
Title
cSBP(central Systolic Blood Pressure)
Description
Average cSBP change after 8 weeks compared to baseline
Time Frame
change after 8 weeks compared to baseline
Secondary Outcome Measure Information:
Title
cDBP(central Diastolic Blood Pressure)
Description
Average cDBP change after 8 weeks compared to baseline
Time Frame
change after 8 weeks compared to baseline
Title
sitSBP(sitting Systolic Blood Pressure)
Description
Average sitSBP change after 8 weeks compared to baseline
Time Frame
change after 8 weeks compared to baseline
Title
sitDBP(sitting Diastolic Blood Pressure)
Description
Average sitDBP change after 8 weeks compared to baseline
Time Frame
change after 8 weeks compared to baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
over 19 years old
Agreement with written informed consent
Hypertensive Patients
Exclusion Criteria:
Patients with secondary hypertension
Participated in other trial within 30 days
In investigator's judgement
Facility Information:
Facility Name
Ajou University Hospital
City
Suwon
State/Province
Gyeonggi-do
Country
Korea, Republic of
Facility Name
Hallym Univ. Medical Center
City
Anyang
Country
Korea, Republic of
Facility Name
Daegu Catholic Univ. Medical Center
City
Daegu
Country
Korea, Republic of
Facility Name
MYONGJI Hospital
City
Goyang-si
Country
Korea, Republic of
Facility Name
Inje University Ilsan Paik Hospital
City
Ilsan-gu
Country
Korea, Republic of
Facility Name
Gachon University Gil Medical Center
City
Incheon
Country
Korea, Republic of
Facility Name
Jeju National University Hospital
City
Jeju
Country
Korea, Republic of
Facility Name
Gangnam Severance Hospital
City
Seoul
Country
Korea, Republic of
Facility Name
Hallym University Kangnam Sacred Heart Hospital
City
Seoul
Country
Korea, Republic of
Facility Name
Hanyang University Medical Center
City
Seoul
Country
Korea, Republic of
Facility Name
Kangbuk Samsung Hospital
City
Seoul
Country
Korea, Republic of
Facility Name
SNU Boramae Medical Center
City
Seoul
Country
Korea, Republic of
Facility Name
Ulsan University Hospital
City
Ulsan
Country
Korea, Republic of
Facility Name
Wonju Severance Christian Hospital
City
Wŏnju
Country
Korea, Republic of
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
We'll reach out to this number within 24 hrs